Coming Soon

Renaphra is a biotechnology company focused on developing innovative solutions for chronic diseases, utilizing proprietary technologies to enhance drug delivery and improve patient outcomes.
Public Funding Received
2020-06-01
Transdermal Fluid Removal - a novel community-based and patient self-administered treatment for fluid overload in heart failure [Continuity]
Feasibility Studies
2019-12-01
Transdermal Fluid Removal - a novel community-based and patient self-administered treatment for fluid overload in heart failure
Collaborative R&D
2018-03-01
Transdermal Fluid Removal - a novel community-based and patient self-administered treatment for fluid overload in heart failure
Feasibility Studies
2015-05-01
Renephra Ltd. Validating commercial opportunity for a novel medical device to treat fluid overload
GRD Proof of Market
2011-10-01
Renephra Ltd
GRD Development of Prototype